Electromed Inc (ELMD)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $198.79M
Last updated: Nov 17, 2026 at 11:04 AM ET
Electromed Inc (ELMD) Financials: Revenue, Profit and Cash Flow
Electromed reported revenue of $73.78M for the fiscal year ended Jun 30, 2026, up 15.3% from the year before. That year, net income was $11.30M with a net margin of 15.3%, operating cash flow was $9.66M and free cash flow was $8.41M. The quarter ended Sep 30, 2026 had revenue of $18.68M and net income of $2.76M.
Revenue and Margins
The operating margin was 18.8% in the fiscal year ended Jun 2026, the highest of the 10 years shown. Over the 9 years to Jun 2026, revenue grew from $25.86M, a compound annual rate of 12.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $73.78M | +15.3% | 78.5% | 18.8% | 15.3% |
| Jun 2025 | $64.00M | +17.0% | 78.1% | 15.1% | 11.8% |
| Jun 2024 | $54.72M | +13.8% | 76.3% | 12.0% | 9.4% |
| Jun 2023 | $48.07M | +15.4% | 76.0% | 8.3% | 6.6% |
| Jun 2022 | $41.66M | +16.5% | 75.5% | 7.1% | 5.5% |
| Jun 2021 | $35.76M | +10.1% | 76.4% | 8.8% | 6.6% |
| Jun 2020 | $32.47M | +3.7% | 77.6% | 15.8% | 12.8% |
| Jun 2019 | $31.30M | +10.6% | 76.2% | 9.0% | 6.3% |
| Jun 2018 | $28.31M | +9.5% | 76.9% | 9.6% | 6.5% |
| Jun 2017 | $25.86M | N/A | 79.5% | 13.8% | 8.6% |
Income Statement
In the fiscal year ended Jun 2026, net income rose 49.9% from the year before. In the quarter ended Sep 2026, net income rose 29.0% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.78M | $64.00M | $54.72M | $48.07M | $41.66M | $35.76M | $32.47M | $31.30M | $28.31M | $25.86M |
| Cost of revenue | $15.83M | $14.03M | $12.99M | $11.55M | $10.22M | $8.45M | $7.27M | $7.45M | $6.53M | $5.29M |
| Gross profit | $57.94M | $49.97M | $41.73M | $36.52M | $31.44M | $27.30M | $25.20M | $23.85M | $21.77M | $20.57M |
| Research and development | $1.31M | $996.00K | $656.00K | $916.00K | $1.36M | $1.72M | $1.05M | $583.31K | $251.44K | $596.88K |
| Operating income | $13.88M | $9.66M | $6.58M | $4.01M | $2.97M | $3.14M | $5.12M | $2.83M | $2.71M | $3.57M |
| Net income | $11.30M | $7.54M | $5.15M | $3.17M | $2.31M | $2.36M | $4.16M | $1.98M | $1.83M | $2.23M |
| EBITDA | $14.96M | $10.83M | $7.42M | $4.62M | $3.60M | $3.75M | $5.86M | $3.76M | $3.51M | $4.34M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.68M | $19.42M | $18.57M | $18.90M | $16.89M | $17.39M | $15.68M | $16.25M | $14.67M | $14.83M | $13.87M | $13.69M |
| Gross profit | $14.94M | $15.28M | $14.64M | $14.82M | $13.20M | $13.62M | $12.23M | $12.63M | $11.49M | $11.30M | $10.38M | $10.54M |
| Operating income | $3.49M | $3.83M | $3.77M | $3.62M | $2.67M | $3.04M | $2.14M | $2.54M | $1.94M | $2.33M | $1.84M | $2.26M |
| Net income | $2.76M | $3.40M | $3.00M | $2.76M | $2.14M | $2.20M | $1.89M | $1.97M | $1.47M | $1.83M | $1.49M | $1.67M |
Balance Sheet
As of Jun 2026, cash and equivalents of $20.45M were 30.9% of total assets of $66.27M, against total liabilities of $12.29M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $66.27M | $53.80M | $52.23M | $45.81M | $41.36M | $37.11M | $33.24M | $29.40M | $8.93M | $23.06M |
| Current assets | $57.37M | $45.08M | $44.17M | $37.79M | $34.54M | $31.70M | $28.02M | $24.54M | $8.23M | $18.48M |
| Cash and equivalents | $20.45M | $15.29M | $16.08M | $7.37M | $8.15M | $11.89M | $10.48M | $7.81M | $7.46M | $5.57M |
| Total liabilities | $12.29M | $10.59M | $7.69M | $8.14M | $7.19M | $4.69M | $3.00M | $3.67M | $805.06K | $3.99M |
| Short-term debt | N/A | $73.00K | $75.00K | $80.00K | N/A | $33.00K | $72.00K | $30.32K | $30.32K | $50.70K |
| Long-term debt | N/A | N/A | N/A | $86.00K | $41.00K | $54.00K | $9.00K | N/A | $14.74K | $1.10M |
| Shareholder equity | $53.98M | $43.21M | $44.55M | $37.67M | $34.17M | $32.42M | $30.25M | $25.73M | $9.52M | $19.07M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $61.09M | $66.27M | $59.47M | $54.91M | $53.61M | $53.80M | $52.45M | $52.27M | $48.91M | $52.23M | $48.90M | $46.96M |
| Total liabilities | $8.62M | $12.29M | $10.31M | $9.47M | $8.87M | $10.59M | $8.51M | $8.67M | $7.43M | $7.69M | $6.36M | $6.62M |
| Cash and equivalents | $15.88M | $20.45M | $16.98M | $13.79M | $14.11M | $15.29M | $15.24M | $16.23M | $13.86M | $16.08M | $11.71M | $10.43M |
| Shareholder equity | $52.47M | $53.98M | $49.17M | $45.44M | $44.74M | $43.21M | $43.94M | $43.60M | $41.49M | $44.55M | $42.54M | $40.34M |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 87.1% of operating cash flow. Share repurchases came to 46.6% of it.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.66M | $11.39M | $9.07M | $1.31M | -$686.00K | $3.08M | $4.20M | $2.59M | $2.44M | $1.19M |
| Capital expenditures | $1.25M | $262.00K | $287.00K | $1.65M | $1.43M | $287.00K | $844.00K | $1.33M | $526.23K | $618.76K |
| Free cash flow | $8.41M | $11.13M | $8.78M | -$333.00K | -$2.11M | $2.79M | $3.35M | $1.26M | $1.92M | $572.36K |
| Share repurchases | $3.92M | $10.00M | $275.00K | $153.00K | $1.45M | $1.12M | $0 | N/A | N/A | N/A |
| Investing cash flow | -$1.30M | -$306.00K | -$395.00K | -$1.72M | -$1.52M | -$448.00K | -$977.00K | -$1.39M | -$571.78K | -$687.15K |
| Financing cash flow | -$3.20M | -$11.88M | $36.00K | -$380.00K | -$1.52M | -$1.22M | -$548.00K | -$851.15K | $11.71K | -$53.62K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $373.00K | $2.99M | $3.48M | $3.03M | $169.00K | $3.86M | $2.07M | $3.15M | $2.31M | $4.49M | $1.35M | $3.47M |
| Capital expenditures | $165.00K | $219.00K | $147.00K | $634.00K | $252.00K | $145.00K | $153.00K | $233.00K | $37.00K | $22.00K | $85.00K | $71.00K |
| Free cash flow | $208.00K | $2.77M | $3.33M | $2.39M | -$83.00K | $3.71M | $1.92M | $2.92M | $2.27M | $4.47M | $1.27M | $3.40M |
Frequently Asked Questions About ELMD
What is Electromed's annual revenue?
Electromed reported revenue of $73.78M for the fiscal year ended Jun 30, 2026.
How fast is Electromed's revenue growing?
Revenue was up 15.3% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 15.4%.
Is Electromed profitable?
Yes. Electromed reported net income of $11.30M for the fiscal year ended Jun 30, 2026, with a net margin of 15.3%.
How much free cash flow does ELMD generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $9.66M minus capital expenditures of $1.25M produced free cash flow of $8.41M.
How much debt does Electromed have?
The balance sheet dated Jun 30, 2026 reported cash and equivalents of $20.45M.
ELMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors